Viewing Study NCT03291418


Ignite Creation Date: 2025-12-25 @ 4:53 AM
Ignite Modification Date: 2026-02-08 @ 3:57 AM
Study NCT ID: NCT03291418
Status: COMPLETED
Last Update Posted: 2018-06-06
First Post: 2017-09-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: To Compare the Gastrointestinal Safety of a 14-Day Oral Dosing Regimen of ATB-346 to Sodium Naproxen in Healthy Subjects
Sponsor: Antibe Therapeutics Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Gastric Ulcer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Healthy Volunteers, ATB-346, Naproxen sodium, GI safety View